Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond
Sellinger J, Gilstad-Hayden K, Lazar C, Seal K, Purcell N, Burgess D, Martino S, Heapy A, Higgins D, Rosen M. Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond. Pain Medicine 2024, 25: s17-s27. PMID: 39514885, PMCID: PMC11548862, DOI: 10.1093/pm/pnae060.Peer-Reviewed Original ResearchConceptsPragmatic clinical trialsHealth careSocial supportChronic painEmotional healthHigher levels of painPain Management CollaboratoryEffective pain managementClinical trialsLevel of painEffectiveness of treatment outcomesPandemic impactAlcohol use disorder screeningCOVID-19-related impactsCOVID-19 pandemicChronic pain treatmentMental healthPain managementDisorder screeningNonpharmacological treatmentsPain treatmentStudy enrollmentCOVID-19HealthCareDo veterans with risky substance use (RSU) use distinct pain treatment modalities?
Meshberg‐Cohen S, Gilstad‐Hayden K, Martino S, Lazar C, Sellinger J, Rosen M. Do veterans with risky substance use (RSU) use distinct pain treatment modalities? American Journal On Addictions 2024, 33: 675-684. PMID: 38849976, DOI: 10.1111/ajad.13620.Peer-Reviewed Original ResearchRisky substance usePain treatment modalitiesTreatment modalitiesPain treatmentPrescribed opioidsPain treatment utilizationSubstance Involvement TestNonopioid pain treatmentPain treatment outcomesSubstance useOver-the-counter medicationsNumerical rating scalePrimary careMusculoskeletal conditionsAssociated with numberPain serviceNonopioid treatmentsPrescription medicationsOpioid medicationsChronic painOpioid prescriptionsOver-the-counterVeteransDisability claimsOpioid